Trial intelligence / Profile preview

Vitamin D dosages in preterm infants with late-onset sepsis

NCT02273843Phase 1Completed

Sponsor
Mansoura University Children Hospital
Start
Sep 2013
Primary completion
Aug 2015
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of vitamin d in late-onset neonatal sepsis (LONS), sponsored by Mansoura University Children Hospital. Primary endpoint: Interleukin-6 at 7 days. Started Sep 2013; status: completed.

02

Drugs

vitamin d
03

Conditions

late-onset neonatal sepsis (LONS)

Beyond the preview

Go deeper on NCT02273843.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02273843.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call